22nd Century Announces Exclusive Worldwide Agreement with KeyGene for Genetic Development of Hemp/Cannabis
WILLIAMSVILLE, N.Y.--(BUSINESS WIRE)--Apr 9, 2019--22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is a leader in tobacco harm reduction, Very L…
